Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Eastern Cooperative Oncology Group
ClinicalTrials.gov Identifier:
NCT00771017
First received: October 9, 2008
Last updated: August 16, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)